Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05767749 · ClinicalTrials.gov registry record · Phase 4
Split Face Study of the Duration of Local Anesthetics
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT05767749 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 75 participants.
The verdict
NCT05767749, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
This is a research study to compare how long injectable pain medications (anesthetics) commonly used in dermatologic surgery are effective for. This study will compare a short-acting anesthetic, lidocaine with epinephrine, to one of two long-acting anesthetics (ropivacaine or bupivacaine). This study will also directly compare the duration of actions of ropivacaine and bupivacaine. The investigators hypothesize that the duration of anesthesia of short-acting anesthetics will not differ significantly from long-acting anesthetics at a single site and there will not be a significant difference between the two long-acting anesthetics at a single site.
Interventions
- DRUG Ropivacaine 0.5% Injectable Solution
- DRUG Bupivacaine 0.5% Injectable Solution
- DRUG lidocaine + epinephrine 1:100,000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2023-03-14 |
| Est. Completion | 2023-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05767749
The ClinicalTrials.gov registry entry for NCT05767749 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ropivacaine 0.5% Injectable Solution is the first listed.
NCT05767749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05767749 about?
NCT05767749 is a clinical study titled "Split Face Study of the Duration of Local Anesthetics". This is a research study to compare how long injectable pain medications (anesthetics) commonly used in dermatologic surgery are effective for. This study will compare a short-acting anesthetic, lidocaine with epinephrine, to one of two long-acting anesthetics (ropivacaine or bupivacaine). This stud...
What is the current status of trial NCT05767749?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2023-03-14. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT05767749?
The interventions under investigation include: Ropivacaine 0.5% Injectable Solution (DRUG), Bupivacaine 0.5% Injectable Solution (DRUG), lidocaine + epinephrine 1:100,000 (DRUG).
Who is sponsoring clinical trial NCT05767749?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.